logo
Plus   Neg
Share
Email

Ryder System Provides Q1, FY19 - Quick Facts

Ryder System, Inc. (R) on Thursday initiated earnings and revenue guidance for the first quarter of fiscal 2019 and the full-year-2019.

The company now projects earnings in a range of $5.18 to $5.48 per share, comparable earnings in a range of $6.00 to $6.30 per share and comparable earnings, excluding new lease accounting standard in a range of $6.20 to $6.50 per share.

Total revenue for the full-year 2019 is forecast to be up 8 percent to about $9 billion and operating revenue to be up 9 percent to about $7 billion.

On average, analysts polled by Thomson Reuters expect the company to earn $6.14 per share on revenue growth of 6.3 percent to $8.87 billion for the year. Analysts' estimates usually exclude special items.

For the first quarter of fiscal 2019, the company expects earnings in a range of $0.71 to $0.78 per share, comparable earnings in a range of $0.96 to $1.03 per share and comparable earnings, excluding new lease accounting standard in a range of $0.94 to $1.01 per share. Analysts are looking for earnings of $1.02 per share for the quarter.

Ryder said it will adopt a new lease accounting standard effective January 1, 2019, which has no impact on cash flow or total earnings over the life of a lease contract. The new standard, however, changes the timing of revenue recognition to better align with maintenance costs. The 2019 forecast for earnings per share was lowered by about $0.20 to reflect this standard.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The National Aeronautics and Space Administration or NASA extended its contract with Boeing to build the rocket core stages for its Space Launch System or SLS beyond the first two Artemis missions, and through the next decade. Boeing is the current lead contractor for the core stages of the rockets for the first two missions. The new contract includes the production of ten SLS core stages. The U.S. Food and Drug Administration approved an all-time record total of 1,171 generic drugs in fiscal 2019, breaking its previous record of 971 approvals in fiscal 2018. This year's approvals include 935 full approvals and 236 tentative approvals. A generic drug is a pharmaceutical drug that contains the same chemical substance and performs the same functions as a branded drug. Air Canada has extended its grounding of Boeing's 737 MAX-8 aircraft and removed it from its flying schedule until February 14, 2020. The airline had earlier said its fleet of 24 grounded jetliners will not join its schedules until January 8, 2020. The Canadian flag carrier said the extension is a result of the ongoing regulatory uncertainty about the timing of the aircraft returning to service.
RELATED NEWS
Follow RTT
>